ERSOT
APLS

Employees Retirement System of Texas’s Apellis Pharmaceuticals APLS Stock Holding History

Employees Retirement System of Texas’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41,000
Closed -$1.85M – 370
2022
Q2 		$1.85M Hold
41,000
– – 0.03% 508
2022
Q1 		$2.08M Buy
+41,000
New +$1.81M 0.02% 542

Other funds holding APLS

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Employees Retirement System of Texas's APLS Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Apellis Pharmaceuticals (APLS) in Q3 2022, closing a stake of 41,000 shares — an estimated $1.85M sold.

Employees Retirement System of Texas first reported a position in APLS in Q1 2022 and held it in 2 quarters. The position peaked at $2.08M in Q1 2022. 250 funds tracked by Wall St. Rank hold APLS as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Apellis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 41,000 Apellis Pharmaceuticals shares in Q3 2022, an estimated $1.85M.
  • Employees Retirement System of Texas first reported a position in Apellis Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Employees Retirement System of Texas's Apellis Pharmaceuticals position peaked at $2.08M in Q1 2022.
  • 250 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.